You are here: Industry Insights > COVID-19

News List

Gilead says remdesivir reduced risk of death in Covid-19 patients, more studies needed expresspharma
July 13, 2020
The company, which had initially released the data from the trial in April, said the finding requires confirmation in clinical trials.
Scientists focus on how immune system T cells fight coronavirus in absence of antibodies expresspharma
July 13, 2020
Recent studies show that some recovered patients who tested negative for coronavirus antibodies did develop T cells in response to their COVID-19 infection.
Bill Gates calls for COVID-19 meds to go to people who need them, not ‘highest bidder’ expresspharma
July 13, 2020
Billionaire philanthropist Bill Gates called for COVID-19 drugs and an eventual vaccine to be made available to countries and people that need them most, not to the “highest bidder,” saying relying on market forces would prolong the deadly pandemic.
Tuberculosis vaccine may be limiting COVID-19 deaths; dormitory screening urged expresspharma
July 13, 2020
Researchers found that countries with higher rates of Bacille Calmette-Guérin (BCG) vaccinations for tuberculosis had lower peak mortality rates from COVID-19.
Pandemic exposes scientific rift over proving when germs are airborne expresspharma
July 13, 2020
The WHO acknowledged this week that the novel coronavirus can spread through tiny droplets floating in the air, a nod to more than 200 experts in aerosol science.
‘Indiscriminate use of remdesivir, tocilizumab on Covid patients can cause more harm than good’ expresspharma
July 13, 2020
It said the pursuit of an effective treatment for COVID-19 has resulted in repurposing of several drugs which are not part of the main Clinical Management Protocol but have been indicated as investigational therapies.
Oriented by Product Innovation, Dongtai Pharma Striving to Build a Global Characteristic Pharmaceutical Brand PharmaSources.com
July 10, 2020
The COVID-19 pandemic in 2020 is a huge test and challenge to Chinese pharmaceutical enterprises. Some have forged ahead, while others have encountered disastrous defeats.
UK researchers back use of steroid inhalers during pandemic pharmatimes
July 10, 2020
Researchers from Huddersfield University say the benefits of using steroid-containing inhalers and nebulisers during the COVID-19 pandemic outweigh the risks, despite warnings to the contrary.
Neutralizing antibodies in the battle against COVID-19 worldpharmanews
July 10, 2020
An important line of defence in the fight against the new corona virus SARS-CoV-2 is the formation of neutralising antibodies.
Researchers call for worldwide biosurveillance network to protect from diseases worldpharmanews
July 10, 2020
The emergence of COVID-19 is a powerful reminder of how unchecked wildlife trade can lead to the spillover spread of viruses between wildlife and humans.